[Federal Register Volume 87, Number 28 (Thursday, February 10, 2022)]
[Notices]
[Pages 7846-7847]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-02823]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel; NINDS Enhancing Experimental 
Rigor.
    Date: March 15-16, 2022.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
    Contact Person: DeAnna Lynn Adkins, Ph.D., Scientific Review 
Officer, Scientific Review Branch, Division of Extramural 
Activities, NINDS/NIH, NSC, 6001 Executive Boulevard, Bethesda, MD 
20892, 301-496-9223, <a href="/cdn-cgi/l/email-protection#d9bdbcb8b7b7b8f7b8bdb2b0b7aa99b7b0b1f7beb6af"><span class="__cf_email__" data-cfemail="167273777878773877727d7f786556787f7e38717960">[email protected]</span></a>.

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel; HEAL Initiative: Planning Studies 
for Initial Analgesic Development [Small Molecules and Biologics] 
(R61 Clinical Trial Not Allowed).
    Date: March 16, 2022.
    Time: 12:30 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.

[[Page 7847]]

    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
    Contact Person: Bo-Shiun Chen, Ph.D., Scientific Review Officer, 
Scientific Review Branch, Division of Extramural Activities, NINDS/
NIH, NSC, 6001 Executive Boulevard, Bethesda, MD 20892, 301-496-
9223, <a href="/cdn-cgi/l/email-protection#cdafa2e0bea5a4b8a3e3aea5a8a38da3a4a5e3aaa2bb"><span class="__cf_email__" data-cfemail="a8cac785dbc0c1ddc686cbc0cdc6e8c6c1c086cfc7de">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS)

    Dated: February 4, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-02823 Filed 2-9-22; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>